Denham refers new round of cancer drugs to NICE
The National Institute for Clinical Excellence is to rule on whether a range of anti-cancer drugs should be available on the NHS. Health minister John Denham has referred a series of treatments to NICE, in a two-year programme. The list covers therapies for lung, colorectal, blood, breast, ovarian, brain and pancreatic cancers. NICE chief executive Andrew Dillon said the institute would contact patient organisations, professional bodies and manufacturers interested in temozolamide for ...
Free to view - simply register with HSJ
Register once to read this article and get access to other registered-user content for free.
This content is free for all registered users to view.
If you have previously registered with HSJ, please enter your email address below.
Not yet registered?
Our registration process is simple and quick, and by registering once you get ongoing access to online content available only to HSJ registered users.
Get full access - now
Subscribe now for immediate access to hsj.co.uk and Health Service Journal magazine
